Apparatus for precisely adjusting the position of workstations in a document printer/copier
    1.
    发明申请
    Apparatus for precisely adjusting the position of workstations in a document printer/copier 审中-公开
    用于精确调整文件打印机/复印机中工作站位置的装置

    公开(公告)号:US20070059070A1

    公开(公告)日:2007-03-15

    申请号:US11591334

    申请日:2006-11-01

    IPC分类号: G03G15/00

    摘要: Apparatus for precisely positioning one or more of the workstations of a document printer/copier relative to an internal drum, including a first member, attached to either a workstation or the internal drum, having two sections, each section having a reference surface forming an angle therebetween, an actuator for changing the included angle between the first reference surface and second reference surface, thus enabling the included angle to be increased or decreased, and a second member having a reference surface that mates with the pair of reference surfaces, associated with the other of the workstation or the internal drum, so as to accurately adjust the workstation relative to the internal drum dependent upon the included angle of the first reference surface and second reference surface.

    摘要翻译: 用于相对于内鼓精确定位文件打印机/复印机的一个或多个工作站的装置,包括附接到工作站或内鼓的第一构件,具有两个部分,每个部分具有形成角度的参考表面 其间具有用于改变第一参考表面和第二参考表面之间的夹角的致动器,从而能够增加或减小夹角,并且具有与所述一对参考表面配合的参考表面的第二构件与第二参考表面相关联 工作站或内鼓中的另一个,以便根据第一参考表面和第二参考表面的夹角,相对于内鼓来精确地调整工作站。

    Antagonists of interleukin-2 receptor
    2.
    发明授权
    Antagonists of interleukin-2 receptor 有权
    白介素-2受体的拮抗剂

    公开(公告)号:US09428567B2

    公开(公告)日:2016-08-30

    申请号:US13997503

    申请日:2011-12-22

    IPC分类号: C07K14/55 A61K38/00

    CPC分类号: C07K14/55 A61K38/00

    摘要: Novel human interleukin-2 (IL-2) muteins or variants thereof, and nucleic acid molecules and variants thereof are provided. Methods for producing these muteins as well as methods for stimulating the immune system of an animal are also disclosed. In addition, the invention provides recombinant expression vectors comprising the nucleic acid molecules of this invention and host cells into which expression vectors have been introduced. Pharmaceutical compositions are included comprising a therapeutically effective amount of a human IL-2 mutein of the invention and a pharmaceutically acceptable carrier. The IL-2 muteins can be used in pharmaceutical compositions for use in treatment of cancer and in stimulating the immune response.

    摘要翻译: 提供了新的人白介素-2(IL-2)突变蛋白或其变体,以及核酸分子及其变体。 还公开了产生这些突变蛋白的方法以及刺激动物的免疫系统的方法。 此外,本发明提供了包含本发明的核酸分子的重组表达载体和已经引入了表达载体的宿主细胞。 包括药物组合物,其包括治疗有效量的本发明的人IL-2突变蛋白和药学上可接受的载体。 IL-2突变蛋白可用于用于治疗癌症和刺激免疫应答的药物组合物中。

    INDUCIBLE SELF-CLEAVING PROTEASE TAG AND METHOD OF PURIFYING RECOMBINANT PROTEINS USING THE SAME
    3.
    发明申请
    INDUCIBLE SELF-CLEAVING PROTEASE TAG AND METHOD OF PURIFYING RECOMBINANT PROTEINS USING THE SAME 审中-公开
    可诱导的自我清除蛋白质标签和使用其来纯化重组蛋白的方法

    公开(公告)号:US20130012687A1

    公开(公告)日:2013-01-10

    申请号:US13261221

    申请日:2010-09-21

    IPC分类号: C12P21/06 C07K14/00

    摘要: A method of purifying a protein is disclosed which entails: a) fusing a site-specific affinity-tagged cysteine protease domain to a target protein to form a tagged fusion protein; b) activating the site-specific cysteine protease domain of the tagged fusion protein by subjecting the site-specific affinity-tagged cysteine protease domain to an inducer, which induces autoprocessing at a cleavage site; thereby releasing untagged target protein; and c) isolating the untagged target protein.

    摘要翻译: 公开了一种纯化蛋白质的方法,其需要:a)将位点特异性亲和标记的半胱氨酸蛋白酶结构域融合到靶蛋白以形成标记的融合蛋白; b)通过使位点特异性亲和标记的半胱氨酸蛋白酶结构域诱导诱导物来激活标记的融合蛋白的位点特异性半胱氨酸蛋白酶结构域,诱导物诱导在切割位点的自动加工; 从而释放未标记的靶蛋白; 和c)分离未标记的靶蛋白。

    SUPERKINES AND SYNTHEKINES: REPURPOSED CYTOKINES WITH NEW AND ENHANCED SIGNALING ACTIVITIES
    4.
    发明申请
    SUPERKINES AND SYNTHEKINES: REPURPOSED CYTOKINES WITH NEW AND ENHANCED SIGNALING ACTIVITIES 有权
    监督和合作:用新的和增强的信号活动修复细胞因子

    公开(公告)号:US20160244499A1

    公开(公告)日:2016-08-25

    申请号:US14419873

    申请日:2013-08-08

    IPC分类号: C07K14/54

    摘要: Disclosed herein are IL-4 cytokine compositions with enhanced biological activity having increased selectivity for IL-4 cytokine receptors, and methods for their use. These compositions encompass interleukin-4 (IL-4) muteins. The disclosed methods encompass administering an IL-4 to treat neoplastic diseases, autoimmune diseases, infectious diseases or for expanding a hematopoietic cell population.

    摘要翻译: 本文公开了具有增强的对IL-4细胞因子受体的选择性的生物活性增强的IL-4细胞因子组合物及其使用方法。 这些组合物包括白细胞介素-4(IL-4)突变蛋白。 所公开的方法包括施用IL-4以治疗肿瘤疾病,自身免疫性疾病,感染性疾病或扩大造血细胞群体。

    SUPERAGONISTS AND ANTAGONISTS OF INTERLEUKIN-2
    10.
    发明申请
    SUPERAGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 有权
    INTERLEUKIN-2的超级和拮抗剂

    公开(公告)号:US20140046026A1

    公开(公告)日:2014-02-13

    申请号:US13997503

    申请日:2011-12-22

    IPC分类号: C07K14/55

    CPC分类号: C07K14/55 A61K38/00

    摘要: Novel human interleukin-2 (IL-2) muteins or variants thereof, and nucleic acid molecules and variants thereof are provided. Methods for producing these muteins as well as methods for stimulating the immune system of an animal are also disclosed. In addition, the invention provides recombinant expression vectors comprising the nucleic acid molecules of this invention and host cells into which expression vectors have been introduced. Pharmaceutical compositions are included comprising a therapeutically effective amount of a human IL-2 mutein of the invention and a pharmaceutically acceptable carrier. The IL-2 muteins can be used in pharmaceutical compositions for use in treatment of cancer and in stimulating the immune response.

    摘要翻译: 提供了新的人白介素-2(IL-2)突变蛋白或其变体,以及核酸分子及其变体。 还公开了产生这些突变蛋白的方法以及刺激动物的免疫系统的方法。 此外,本发明提供了包含本发明的核酸分子的重组表达载体和已经引入了表达载体的宿主细胞。 包括药物组合物,其包括治疗有效量的本发明的人IL-2突变蛋白和药学上可接受的载体。 IL-2突变蛋白可用于用于治疗癌症和刺激免疫应答的药物组合物中。